Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. W1810 Long-Term Outcome At Year 5 in Chronic Hepatitis B (CHB) Patients Initially Treated with Adefovir Dipivoxil (ADV) in a Real-Life Clinical Setting
  1. Home
  2. Publications
  3. W1810 Long-Term Outcome At Year 5 in Chronic Hepatitis B (CHB) Patients Initially Treated with Adefovir Dipivoxil (ADV) in a Real-Life Clinical Setting

W1810 Long-Term Outcome At Year 5 in Chronic Hepatitis B (CHB) Patients Initially Treated with Adefovir Dipivoxil (ADV) in a Real-Life Clinical Setting

Authors:
  • NHNghiem B. Ha
    Nghiem B. Ha
  • RGRuel T. Garcia
    Ruel T. Garcia
  • HTHuy N. Trinh
    Huy N. Trinh
  • HNHuy A. Nguyen
    Huy A. Nguyen
  • KNKhanh K. Nguyen
    Khanh K. Nguyen
  • Mindie H. Nguyen
    Mindie H. Nguyen

Publisher website
Google Scholar
  • 31 May 2009
    • journal article
    • abstracts
    • Published by Elsevier in Gastroenterology
    • Vol. 136  (5) , A-866-866
    • DOI:10.1016/s0016-5085(09)63996-2
Abstract
No abstract available
Keywords
  • CHB
  • W1810 LONG
  • HEPATITIS
  • ADEFOVIR DIPIVOXIL
  • LIFE CLINICAL
  • INITIALLY TREATED
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.